605507 國邦醫藥
按盤價 
20.990 +1.900 (+9.953%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.394 | 8.397 | 13.642 | 14.677 | 27.500 |
| 總資產報酬率 ROA (%) | 3.957 | 6.312 | 11.125 | 10.844 | 15.777 |
| 投入資產回報率 ROIC (%) | 4.295 | 6.816 | 11.966 | 11.907 | 16.672 | 邊際利潤分析 |
| 銷售毛利率 (%) | 26.596 | 23.410 | 27.549 | 30.136 | 34.007 |
| 營業利潤率 (%) | 16.335 | 13.128 | 18.404 | 17.951 | 22.255 |
| 息稅前利潤/營業總收入 (%) | 15.316 | 12.176 | 16.914 | 18.530 | 24.374 |
| 淨利潤/營業總收入 (%) | 13.981 | 11.403 | 16.092 | 15.675 | 19.264 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.693 | 99.567 | 101.981 | 104.112 | 99.296 |
| 價值變動淨收益/利潤總額(%) | 3.467 | 3.378 | 2.327 | 1.306 | 0.350 |
| 營業外收支淨額/利潤總額(%) | -1.804 | -0.661 | -1.665 | -0.247 | 0.776 | 償債能力分析 |
| 流動比率 (X) | 2.262 | 2.222 | 2.754 | 3.959 | 1.456 |
| 速動比率 (X) | 1.671 | 1.663 | 1.998 | 2.824 | 0.954 |
| 資產負債率 (%) | 24.894 | 28.224 | 20.884 | 15.538 | 40.563 |
| 帶息債務/全部投入資本 (%) | 18.282 | 21.962 | 14.692 | 8.799 | -- |
| 股東權益/帶息債務 (%) | 445.781 | 354.226 | 578.533 | 1,034.220 | 204.726 |
| 股東權益/負債合計 (%) | 301.491 | 254.135 | 378.870 | 543.618 | 146.558 |
| 利息保障倍數 (X) | -20.996 | -14.074 | -14.227 | 29.758 | 12.531 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.520 | 40.360 | 34.998 | 33.151 | 0.000 |
| 存貨周轉天數 (天) | 114.644 | 122.036 | 118.058 | 131.463 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
